In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genesis Pharma SA

www.genesispharma.com

Latest From Genesis Pharma SA

Pharmamar: Yondelis and beyond

The Spanish biotech company Pharmamar, has its sights set on expansion and has opened its first operations outside its home market in Italy. The firm's managing director, Luis Mora, spoke to Scrip about why Italy was a first good bet and what it plans to do beyond Yondelis (trabectedin), the only product it has so far brought to the market.

Cancer Spain

Pharma companies to get €3bn worth of debt paid off from Greek state

The pharmaceutical industry thinks a new dawn has arrived in debt-ridden Greece after it finalised an agreement with the government, which will see drug firms get a mix of cash and bonds for the outstanding hospital debt owed to them for the 2007-2010 period, amounting to some €3 billion. This has been one of the key battles the industry has been trying to reach settlement on.

Greece

Executive Briefing - The biotech company league table

The world's first biotechnology company, Genentech, was founded in 1976. 30 years later there were 4,275 biotechnology companies worldwide, of which 710 were publicly listed. Dr Peter Charlish reviews the fortunes of the top 100 biotech companies involved in human healthcare on the basis of product sales and R&D investment

Gastrointestinal Metabolic Disorders

The Rise of Regional Dealmaking

Biotechs' drive to retain a bigger chunk of downstream rights is forcing product-hungry Big Pharma to accept non-global licensing deals. They'll be up against existing regional players, more accustomed to sharing rights and prioritizing others' drugs.
BioPharmaceutical Middle East and Africa
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Greece
  • Parent & Subsidiaries
  • Genesis Pharma SA
  • Senior Management
  • Costas Evripides, CEO
    Alex Jacovides , Pres.
    Mihalis Ranakis, VP, Fin. & International
  • Contact Info
  • Genesis Pharma SA
    Phone: (30) 210 877 1500
    274 Kifisias Avenue
    Athens, GR-152 32
    Greece
Advertisement
Advertisement
UsernamePublicRestriction

Register